A detailed history of Nwam LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Nwam LLC holds 13,194 shares of LLY stock, worth $10.5 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
13,194
Holding current value
$10.5 Million
% of portfolio
0.73%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $10.2 Million - $12.7 Million
13,194 New
13,194 $11.7 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $79,354 - $106,165
134 Added 1.02%
13,275 $10.3 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $820,346 - $967,081
1,562 Added 13.49%
13,141 $7.66 Million
Q3 2023

Oct 31, 2023

SELL
$434.7 - $599.3 $863,314 - $1.19 Million
-1,986 Reduced 14.64%
11,579 $6.22 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $781,097 - $1.04 Million
2,227 Added 19.64%
13,565 $6.36 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $50,322 - $59,100
-162 Reduced 1.41%
11,338 $3.89 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $2.38 Million - $2.77 Million
7,405 Added 180.83%
11,500 $4.21 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $69,969 - $79,737
236 Added 6.12%
4,095 $1.32 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $95,049 - $118,122
405 Added 11.73%
3,859 $1.11 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $5,171 - $6,417
23 Added 0.67%
3,454 $954,000
Q3 2021

Nov 03, 2021

SELL
$221.6 - $272.71 $33,904 - $41,724
-153 Reduced 4.27%
3,431 $793,000
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $45,137 - $58,385
250 Added 7.5%
3,584 $823,000
Q1 2021

Apr 23, 2021

SELL
$164.32 - $212.72 $46,666 - $60,412
-284 Reduced 7.85%
3,334 $623,000
Q4 2020

Jan 22, 2021

BUY
$130.46 - $172.63 $472,004 - $624,575
3,618 New
3,618 $611,000
Q3 2020

Oct 16, 2020

SELL
$146.22 - $169.13 $556,513 - $643,708
-3,806 Closed
0 $0
Q2 2020

Jul 21, 2020

BUY
$136.42 - $164.18 $19,235 - $23,149
141 Added 3.85%
3,806 $625,000
Q4 2019

Jan 23, 2020

BUY
$106.92 - $132.43 $30,365 - $37,610
284 Added 8.4%
3,665 $482,000
Q3 2019

Oct 15, 2019

BUY
$106.79 - $116.16 $5,339 - $5,808
50 Added 1.5%
3,381 $378,000
Q4 2018

Jan 30, 2019

BUY
$105.9 - $118.64 $352,752 - $395,189
3,331 New
3,331 $385,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nwam LLC Portfolio

Follow Nwam LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.